Osimertinib With Ramucirumab in EGFR Mutated, T790m-Positive Patients Who Had Progressed EGFR-TKIs: Phase Ib Study
Clinical Lung Cancer - United States
doi 10.1016/j.cllc.2018.08.001
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2018
Authors
Publisher
Elsevier BV